Yellowstone Biosciences
PrivateLast Round
Series A
Jun 20, 2024
Total Funding Raised
$21M
Company Overview
Yellowstone Biosciences is a biotechnology company that develops soluble bispecific T-cell receptor-based therapies targeting HLA Class II antigens for the treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Yellowstone Biosciences Comparables
Compare Yellowstone Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Stereo Biotherapeutics | 80% | |
| Enara Bio | 78% | |
| T-knife Therapeutics | 78% |
Yellowstone Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 20, 2024 |
Key People
Founding team and executive leadership
Yellowstone Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Syncona | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 18, 2025
James (Jim) MacDonald appointed as new Chief Executive Officer and Board member.
- Jun 8, 2025
Grew 18% QoQ, from 22 to 26 employees.
Yellowstone Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Yellowstone Biosciences's valuation, stock price, and market status.
Is Yellowstone Biosciences a public or private company?
Yellowstone Biosciences is a private company.
What is the current stock price of Yellowstone Biosciences?
Yellowstone Biosciences is a private company with no public stock price. No recent secondary market data is available.
How much is Yellowstone Biosciences worth (valuation)?
Valuation information for Yellowstone Biosciences is not publicly available.
Can I buy Yellowstone Biosciences stock?
Yellowstone Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Yellowstone Biosciences's last funding round?
Yellowstone Biosciences's most recent funding round was Series A on June 20, 2024.
Who are the main investors in Yellowstone Biosciences?
Key investors in Yellowstone Biosciences include Syncona.
Will Yellowstone Biosciences IPO soon?
No public IPO plans have been announced for Yellowstone Biosciences.
How can I track Yellowstone Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Yellowstone Biosciences's secondary market activity and sign up for updates.